How effective is Leucovorin Calcium for Rheumatoid Arthritis? (by duration, gender, age)
Summary:
Overall ratings: 3.2/5 Long term ratings: 3.3/5
This is a phase IV clinical study of how effective Leucovorin calcium (leucovorin calcium) is for Rheumatoid arthritis and for what kind of people. The study is created by eHealthMe from 13 Leucovorin calcium users and is updated continuously.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
13 people are studied for taking Leucovorin calcium in Rheumatoid arthritis
What is Leucovorin calcium?
Leucovorin calcium has active ingredients of leucovorin calcium. It is used in rheumatoid arthritis. Currently, eHealthMe is studying from 22,779 Leucovorin calcium users.
What is Rheumatoid arthritis?
Rheumatoid arthritis (a chronic progressive disease causing inflammation in the joints) is found to be associated with 2,644 drugs and 2,038 conditions by eHealthMe. Currently, we are studying 1,046,740 people who have Rheumatoid arthritis.
Overall effectiveness (number of people):
Long term (1+ years) effectiveness (number of people):
Leucovorin calcium effectiveness for Rheumatoid arthritis (number of people):
Overall:
- not at all: 0
- somewhat: 5
- moderate: 3
- high: 3
- very high: 2
Long Term:
- not at all: 0
- somewhat: 3
- moderate: 2
- high: 2
- very high: 2
Gender of people who take Leucovorin calcium for Rheumatoid arthritis *:
- female: 92.31 %
- male: 7.69 %
Age of people who take Leucovorin calcium for Rheumatoid arthritis *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 7.69 %
- 20-29: 0.0 %
- 30-39: 23.08 %
- 40-49: 23.08 %
- 50-59: 23.08 %
- 60+: 23.08 %
Who find Leucovorin Calcium more effective for Rheumatoid Arthritis?
Gender of people who take Leucovorin calcium for Rheumatoid arthritis *:
- female: 100 %
- male: 0.0 %
Age of people who take Leucovorin calcium for Rheumatoid arthritis *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 20 %
- 40-49: 0.0 %
- 50-59: 40 %
- 60+: 40 %
* Approximation only. Some reports may have incomplete information.
Do you take Leucovorin calcium?
- You can start a phase IV clinical trial to monitor Leucovorin calcium safety and effectiveness.How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies:
- Mathai, P. C., Andrade, N. N., Aggarwal, N., Nerurkar, S., & Kapoor, P. , "Low-dose methotrexate in rheumatoid arthritis: a potential risk factor for bisphosphonate-induced osteonecrosis of the jaw", Oral and maxillofacial surgery, 2018 Jan .
- Azuma N, Matsui K, Hashimoto N, Yoshikawa T, Sano H, "Successful Switch to Golimumab for Eosinophilia and Skin Symptoms Related to Multiple Biologics in a Patient with Rheumatoid Arthritis", Internal Medicine, 2017 Jun .
- Saif MW, "Rheumatoid arthritis associated with the use of Sandostatin? LAR? depot in a patient with pancreatic neuroendocrine tumor", An association or a coincidence? The first case report, 2017 Jan .
- Ahmed AB, Radwan AM, Baddary HM, "Prevalence of Generalized Anxiety Disorder in Patients with Rheumatoid Arthritis and its Relationship with Disease Activity", The Egyptian Journal of Hospital Medicine, 2016 Jan .
Related studies
Alternative drugs to, pros and cons of:
- Leucovorin calcium (22,779 reports)
Treatments, associated drugs and conditions:
- Rheumatoid arthritis (1,046,740 reports)
How the study uses the data?
The study is based on leucovorin calcium (the active ingredients of Leucovorin calcium) and Leucovorin calcium (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study neither.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Silodosin and Zyloprim drug interaction - 8 seconds ago
- Solu-Medrol and Striverdi Respimat drug interaction - 9 seconds ago
- Pegasys and Permethrin drug interaction - 31 seconds ago
- Bethanechol Chloride and Actos drug interaction - 37 seconds ago
- Carvedilol and Paraplatin drug interaction - 46 seconds ago
- Topiramate and Benlysta drug interaction - a minute ago
- Crestor and Videx Ec drug interaction - a minute ago
- Suboxone and Lotemax drug interaction - a minute ago
- Valsartan and Tysabri drug interaction - 2 minutes ago
- Fosphenytoin Sodium and Metoclopramide drug interaction - 2 minutes ago